Coordinator
Lead Coordinator
-
Prof. Dr. med. A. Günther
(RA „Fibrotic Repair & Remodeling“)Section Head
“Interstitial and Rare Lung Diseases”
University Hospital Gießen & Marburg
Justus-Liebig-University Gießen
Klinikstrasse 33
D – 35392 Gießen
andreas.guenther@innere.med.uni-giessen.deMedical Chair
AGAPLESION Lung Clinic Waldhof-Elgershausen
D – 35753 Greifenstein
a.guenther@klinikwaldhof.de
- Prof. Dr. med. A. Günther (representing the RA „Fibrotic Repair & Remodeling“. Andreas Günther is board certified physician in Internal Medicine, Pulmonary and Critical Care and Sleep Medicine and W3 Professor of Internal Medicine at the JLU. He leads a Center for Interstitial and Rare Lung Diseases at the University Hospital Giessen (UKGM) and a specialized Lung Clinic (Ev. Krankenhaus in Gießen). Prof. Günther conducts several pharma-sponsored clinical, as well as in investigator-driven studies (30). He is speaker of the Clinical Research Unit (CRU) “Pathomechanism and Therapy of Lung Fibrosis” (KFO 118, initial funding DFG) and coordinates the European IPF/ILD Registry/Biobank (initial funding EU FP7) and a recently funded European Network on ILD (RARE-ILD, EU-EJP-RD program). He also coordinates the disease area “Diffuse Parenchymal Lung Diseases” of the “University of Giessen and Marburg Lung Center” (Excellency program LOEWE) and the “German Center for Lung Research” (DZL, BMBF), the discovery area “Cellular Surveillance” of the excellency cluster “Cardiopulmonary Institute” (CPI, DFG) and the platform “Biobanking and Data Management” (DZL). His main research interest includes mechanisms of alveolar epithelial injury, regeneration and repair and alveolar homeostasis. As of January 2021, he has published 213 original manuscripts in international, peer-reviewed journals, 54 invited reviews, editorials or commentaries, 14 book-, 4 textbook chapters. Prof. Günther received the Heisenberg stipend (DFG), the Young Investigator Award (German Society of Pneumology) and the Oscar Medicine Prize (Oskar Helene Heim Foundation). He has profound experience as lecturer in the fields of Internal Medicine and in the International Graduate Program “Molecular Biology and Medicine of the Lung” (MBML) and was rewarded twice “Best Teacher of the Year”. He also supervised a larger group of medical (n=64) and PhD (n=17) students.
Coordinator
-
Prof. Dr. med. S. Herold, PhD
(RA „Imbalanced Inflammation & Infection“)Head
Clinical Section of Infectious Diseases
University Hospital Gießen & Marburg
Justus-Liebig-University Gießen
Klinikstrasse 33
D – 35392 Gießen
Susanne.herold@innere.med.uni-giessen.de
- Prof. Dr. med. S. Herold, PhD (representing the RA „Imbalanced Inflammation & Infection“. SUSANNE HEROLD IS W3 PROFESSOR FOR PULMONARY INFECTIONS AT THE JLU-FM, COORDINATOR OF THE CLINICAL RESEARCH UNIT KFO309 (VIRUS-INDUCED LUNG INJURY) AND HEAD OF THE INFECTIOUS DISEASES SECTION AT THE DEPARTMENT OF MEDICINE II OF THE UKGM. SHE IS BOARD CERTIFIED IN INTERNAL MEDICINE, INFECTIOUS DISEASES AND PULMONARY MEDICINE. HER RESEARCH HAS BEEN FOCUSED ON THE PATHOMECHANISMS OF PNEUMONIA-INDUCED ACUTE LUNG INJURY AND REPAIR AND HAS DELIVERED THERAPEUTIC APPROACHES NOW BEING TESTED IN INVESTIGATOR-INITIATED CLINICAL PHASE II/III TRIALS IN THE CONTEXT OF COVID-19 AND BEYOND. SHE IS FUNDED IN MULTIPLE COLLABORATIVE PROJECT GRANTS (SFB-TR84, SFB1021, KFO309, NUM), INVOLVED IN MANY INTERNATIONAL SCIENTIFIC RESEARCH ACTIVITIES, AND HOLDS AN APPOINTMENT AS ADJUNCT PROFESSOR AT THE DEPARTMENT OF PULMONARY AND CRITICAL CARE MEDICINE AT NORTHWESTERN UNIVERSITY OF CHICAGO. SHE IS VICE PRESIDENT OF THE GERMAN SOCIETY OF INFECTIOUS DISEASES (DGI) AND COORDINATOR OF THE DISEASE AREA “PNEUMONIA AND ARDS” OF THE DZL, AND FACULTY MEMBER OF THE EXCELLENCE CLUSTER CPI. SHE IS A LECTURER AT THE JLU-FM AND IN THE MBML GRADUATE PROGRAM, AND HAS BEEN A SUPERVISOR OF SEVERAL DR. MED. STUDENTS AND 14 PHD AND MD/PHD STUDENTS, OUT OF WHICH MANY GRADUATED summa cum laude.
Coordinator
-
Prof. Dr. med. T. Acker
(RA „Cancer Evolution & Progression“)Director
Institute for Neuropathology
University Hospital Gießen Marburg
Justus-Liebig-University Gießen
Arndtstrasse 16
D – 35392 Gießen
till.acker@patho.med.uni-giessen.deVice Dean for Research
Faculty of Human Medicine
Klinikstrasse 29
D – 35392 Gießen
- Prof. Dr. med. T. Acker (representing the RA „Cancer Evolution & Progression“). Till Acker is W3 Professor and director of the institute of neuropathology in Giessen and at present president of the German society of neuropathology and neuroanatomy. He is deputy speaker of MIRACUM, a consortium of ten university clinics funded by the Federal Ministry of Education and Research aiming to improve use of big data for health care and patient-centered collaborative research. Since 2021, he is also speaker of LOEWE consortium „iCANx – Cancer – Lung (Disease) Crosstalk: Tumor and Organ Microenvironment“. Since 2015, Till Acker is dean of research of the JLU-FM and coordinats research funding and training programs for medical students and clinical/medical scientist. Till Acker serves as a reviewer and advisor for several national / international funding agencies as well various scientific journals including Nature, Nature Cell Biology, JEM, JNCI. Ongoing work focuses on the understanding of how stress-sensing mechanisms shape the aggressive tumor phenotype and regulate therapy resistance. His lab has pioneered work on the microenvironmental role of HIFs and the stress sensors PHDs in setting the hallmarks of cancer including metastasis and invasion, tumor stem cells, angiogenesis and proliferative signalling. Clinically, his group is particularly interested in the translational discovery and application of biomarkers through next generation sequencing techniques and applied AI for the differential diagnosis and the prediction of therapy responses in brain tumors. He has published 99 peer-reviewed publications. Till Acker received a Max-Eder-Junior Research Group grant from the German Cancer Aid and is lecturer for Neuropathology at the Justus-Liebig University. He has been supervisor to 17 medical theses and 9 Ph.D. students.